Indication
Atrioventricular Septal Defect
1 clinical trial
2 products
Clinical trial
A Phase III Double-Blind, Randomized, Placebo Controlled, Multi Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart DefectsStatus: Recruiting, Estimated PCD: 2023-12-31
Product
L-citrullineProduct
Plasmalyte A